Rheumatoid arthritis

A meta-analysis of the association between the ATIC 347 C/G polymorphism and methotrexate responsiveness and toxicity in rheumatoid arthritis

Semin Arthritis RheumPublished Systematic review and meta-analysis

Pooled result · Failure to respond to MTXResult — go to the resultOdds ratio 0.741 95% CI 0.591–0.929

Authors' conclusion

This meta-analysis revealed that ATIC 347 C/G polymorphism was related to non-responsiveness to MTX in European populations with RA. However, no significant correlation was found with MTX toxicity.

Study context

Population
Patients with rheumatoid arthritis (RA) treated with methotrexate (MTX)
Participants
3,185 patients13 studies
Comparison
ATIC 347 GG genotype vs other genotypes
Outcome
MTX non-responsiveness and MTX toxicity
Methodological detailsstratification by ethnicity
  • Stratification by ethnicity

Pooled result

Failure to respond to MTX

Odds ratio

0.741

95% CI 0.591–0.929

P = 0.009

ATIC 347 GG genotypevs other genotypes
OR 0.741 (95% CI 0.591–0.929); P = 0.009

As reported in the abstract

Further pooled results

MTX non-responsiveness by ethnicity (subgroups)

OR (95% CI)P value
ATIC 347 GGEuropeans0.548 (0.377–0.796)P = 0.002
ATIC 347 GGAsian populations0.882 (0.665–1.1172)P = 0.388

Safety

MTX toxicity

OR (95% CI)P value
ATIC 347 GG7 studies on MTX toxicity1.278 (0.937–1.745)P = 0.121

MTX toxicity by ethnicity (subgroups)

OR (95% CI)P value
ATIC 347 GGAsian1.252 (0.905–1.732)P = 0.175
ATIC 347 GGEuropean1.617 (0.549–4.765)P = 0.383

Original publication

A meta-analysis of the association between the ATIC 347 C/G polymorphism and methotrexate responsiveness and toxicity in rheumatoid arthritis. Semin Arthritis Rheum. Published 30 November 2023. doi:10.1016/j.semarthrit.2023.152337

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.